Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02039557 · ClinicalTrials.gov registry record
Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients
A clinical trial, sponsored by Gamida Cell.
- Completed
- Registry status
- 33
- Enrollment target
NCT02039557 is a clinical trial that has completed, run by Gamida Cell. The registered enrollment target is 33 participants.
The verdict
NCT02039557 has completed, sponsored by Gamida Cell.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.
Interventions
- GENETIC NiCord®/CordIn™ (omidubicel)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2014-05-01 |
| Est. Completion | 2023-06-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02039557
The ClinicalTrials.gov registry entry for NCT02039557 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gamida Cell, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NiCord®/CordIn™ (omidubicel) is the first listed.
NCT02039557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02039557 about?
NCT02039557 is a clinical study titled "Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients". This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.
What is the current status of trial NCT02039557?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2014-05-01. Estimated completion is 2023-06-29.
What interventions are being tested in trial NCT02039557?
The interventions under investigation include: NiCord®/CordIn™ (omidubicel) (GENETIC).
Who is sponsoring clinical trial NCT02039557?
This trial is sponsored by Gamida Cell, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.